Nasonex Allergy nasal spray

Nasonex is a globally recognized brand specializing in corticosteroid nasal sprays for the treatment of allergy symptoms. Originally developed as a prescription medication, it has successfully transitioned to an over-the-counter (OTC) status in many markets worldwide. The brand's history is rooted in pharmaceutical innovation, specifically the use of mometasone furoate to provide long-lasting relief from nasal inflammation.

Today, the brand's ownership is split across different regions. In much of the world, including the United States, the consumer health portfolio for Nasonex is managed by Organon, a company spun off from Merck & Co. (known as MSD outside the US). However, in specific markets such as Australia and parts of Europe, the distribution and naming rights may involve partnerships or specific pharmaceutical groups like Bayer or Perrigo depending on local regulatory divisions. Manufacturing takes place in several high-tech pharmaceutical facilities across Europe and North America to ensure global supply standards are met.